ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Fred Hutchinson Cancer Center Lung SPORE

Active
Institution
FRED HUTCHINSON CANCER CENTER, WA
Principal investigator
A Mcgarry Houghton
Funding
$2.5M
Duration
2019–2030
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary/Abstract – Overall The Fred Hutch Lung SPORE consists of three innovative projects, three supportive cores, and the required Developmental Research Program and Career Enhancement Program. We have leveraged the strengths of the investigators and our Center to tackle three critical barriers precluding meaningful improvements in lung cancer survival rates: lack of effective therapies for small cell lung cancer (SCLC), sub-optimal response rates of non- small cell lung cancer (NSCLC) patients to immune checkpoint inhibitor therapy, and the lack of effective targeted therapies for KRAS mutant lung cancers. To overcome these barriers, we propose the following three projects: 1) Targeting the Neutrophil Lineage to Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC, 2) Treating metastatic lung cancer by targeting mutated KRAS with engineered T cells, and 3) Targeting LSD1 to augment response to PDL1 inhibition in SCLC. These projects will be supported by an Administrative Core (AC), a Biostatistics and Data Science Core (BDSC), and a Histopathology and Biospecimen Core (HBC).

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEP50Special Emphasis Panel[ZCA1 RPRB-8 (M1)]nsclclung cancerlunglack effectivefredcheckpoint inhibitorsclcsmall cell

Questions for FRED HUTCHINSON CANCER CENTER

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.